Affiliation:
1. Lifespan and Population Health, School of Medicine, University of Nottingham , Nottingham, UK
2. Department of Rheumatology, Nottingham University Hospitals NHS Trust , Nottingham, UK
Abstract
Abstract
Objectives
To comprehensively review systematic reviews of prevalence, incidence, and mortality of Raynaud’s, Sjögren’s and Scleroderma, and to identify any research gaps.
Methods
An umbrella review of English language systematic reviews was undertaken using PubMed and Embase (OVID) covering the period 2000–2023 (PROSPERO CRD42023434865). The estimate and its corresponding 95% confidence interval were reported when available from each systematic review. The quality of systematic reviews was assessed using the Scottish Intercollegiate Guidelines Network (SIGN) tool. A narrative synthesis was undertaken.
Results
Seventeen systematic reviews were identified, of which 1 was for RP, 5 for Sjögren’s and 11 for Scleroderma. There were some high-quality systematic reviews for Sjögren’s and mortality of Scleroderma. However, there were only low-quality systematic reviews of prevalence and incidence of RP and Scleroderma. Furthermore, there were no systematic reviews for the mortality of RP. For RP, the pooled prevalence was 4850 per 100 000; pooled annual incidence was 250 per 100 000. For Sjögren’s, prevalence was 60–70 per 100 000; annual incidence was 6.92 per 100 000 and the pooled standardized mortality ratio ranged from 1.38 to 1.48. For Scleroderma, pooled prevalence ranged from 17.6 to 23 per 100 000; annual incidence was 1.4 per 100 000; and the pooled standardized mortality ratio ranged from 2.72 to 3.53.
Conclusion
The outcomes of RP were less well described compared with Sjögren’s and Scleroderma. There was a lack of high-quality systematic reviews for the prevalence and incidence of RP and Scleroderma. Therefore, further studies and systematic reviews with rigorous case definitions, assessing different ethnic groups are warranted in this area.
Publisher
Oxford University Press (OUP)
Reference29 articles.
1. Prevalence, risk factors and associations of primary Raynaud’s phenomenon: systematic review and meta-analysis of observational studies;Garner;BMJ Open,2015
2. Environmental factors in the pathogenesis of primary Sjogren’s syndrome;Bjork;J Intern Med,2020
3. Epigenetics of scleroderma: integrating genetic, ethnic, age, and environmental effects;Ramos;J Scleroderma Relat Disord,2019
4. Rate, risk factors and causes of mortality in patients with Sjögren’s syndrome: a systematic review and meta-analysis of cohort studies;Singh;Rheumatology (Oxford),2016
5. Mortality in patients with primary Sjogren’s syndrome: a systematic review and meta-analysis;Huang;Rheumatology (Bulgaria),2021